Showing results (571-580 of 3,868) with videos related to
Sort By:
Pageof 387
Cancer Biology & Therapy|March 18, 2010
Modulation of the anti-cancer efficacy of microtubule-targeting agents by cellular growth conditionsJay F Dorsey, Melissa L Dowling, Mijin Kim, et al.Cancer Biology & Therapy|March 18, 2010
MCF-7 breast cancer cells selected for tamoxifen resistance acquire new phenotypes differing in DNA content, phospho-HER2 and PAX2 expression, and rapamycin sensitivityEuphemia Leung, Nagarajan Kannan, Geoffrey W Krissansen, et al.Cancer Biology & Therapy|March 18, 2010
PND-1186 FAK inhibitor selectively promotes tumor cell apoptosis in three-dimensional environmentsIsabelle Tanjoni, Colin Walsh, Sean Uryu, et al.Cancer Biology & Therapy|March 18, 2010
Oral delivery of PND-1186 FAK inhibitor decreases tumor growth and spontaneous breast to lung metastasis in pre-clinical modelsColin Walsh, Isabelle Tanjoni, Sean Uryu, et al.Cancer Biology & Therapy|January 21, 2010
The metal-responsive transcription factor-1 protein is elevated in human tumorsYihui Shi, Khalid Amin, Barbara G Sato, et al.Cancer Biology & Therapy|January 12, 2010
Inhibition of mammalian target of rapamycin as a therapeutic strategy in the management of bladder cancerJose J Mansure, Roland Nassim, Simone Chevalier, et al.Cancer Biology & Therapy|December 17, 2009
Early growth response 1 (EGR1): a gene with as many names as biological functionsJ Thomas DeLigio, Diego A R ZorioCancer Biology & Therapy|December 17, 2009
The overexpression of ERCC-1 is involved in the resistance of lung cancer cells to cetuximab combined with DDPJing-Jing Li, Ya Ding, Dan-Dan Li, et al.Cancer Biology & Therapy|December 17, 2009
Delocalization of gamma-tubulin due to increased solubility in human breast cancer cell linesEdward H Cho, Rebecca A Whipple, Michael A Matrone, et al.Cancer Biology & Therapy|December 17, 2009
Targeting pericytes with a PDGF-B aptamer in human ovarian carcinoma modelsChunhua Lu, Mian M K Shahzad, Myrthala Moreno-Smith, et al.Pageof 387